Review
Drug-induced hepatotoxicity: pharmacokinetic perspectives and strategies for risk reduction
Affiliations
- PMID: 10687025
Item in Clipboard
Review
Drug-induced hepatotoxicity: pharmacokinetic perspectives and strategies for risk reduction
Adverse Drug React Toxicol Rev.
1999 Nov.
No abstract available
Similar articles
-
The Dunlop phenomena: a lesson in risk management from an unlikely source.Med Device Technol. 2003 Apr;14(3):9-10. Med Device Technol. 2003. PMID: 12789692
-
Anti tubercular treatment induced hepatotoxicity: does acetylator status matter?Indian J Physiol Pharmacol. 1995 Jan;39(1):43-6. Indian J Physiol Pharmacol. 1995. PMID: 7705868
-
The role of metabolism in the hepatotoxicity of isoniazid and iproniazid.Drug Metab Rev. 1979;10(1):125-47. doi: 10.3109/03602537908993904. Drug Metab Rev. 1979. PMID: 393481 Review. No abstract available.
-
Proceedings: The role of cytochrome P-450 in carbon tetrachloride-induced hepatic injury.J Am Osteopath Assoc. 1976 Jan;75(5):537. J Am Osteopath Assoc. 1976. PMID: 1044321 No abstract available.
-
Reactive metabolites as a cause of hepatotoxicity.Int J Clin Pharmacol Res. 1983;3(6):437-41. Int J Clin Pharmacol Res. 1983. PMID: 6381340 Review.
Cited by
-
Drug development and use in the elderly: search for the right dose and dosing regimen (Parts I and II).Br J Clin Pharmacol. 2004 Nov;58(5):452-69. doi: 10.1111/j.1365-2125.2004.02228.x. Br J Clin Pharmacol. 2004. PMID: 15521892 Free PMC article. Review. No abstract available.
-
Importance of Publishing Adverse Drug Reaction Case Reports: Promoting Public Health and Advancing Pharmacology and Therapeutics.Drug Saf Case Rep. 2017 Sep 20;4(1):11. doi: 10.1007/s40800-017-0053-0. Drug Saf Case Rep. 2017. PMID: 28933008 Free PMC article.
-
Withdrawal of prenylamine: perspectives on pharmacological, clinical and regulatory outcomes following the first QT-related casualty.Ther Adv Drug Saf. 2018 Jun 18;9(8):475-493. doi: 10.1177/2042098618780854. eCollection 2018 Aug. Ther Adv Drug Saf. 2018. PMID: 30364900 Free PMC article. Review.
-
Value of preapproval safety data in predicting postapproval hepatic safety and assessing the legitimacy of class warning.Ther Adv Drug Saf. 2012 Feb;3(1):13-24. doi: 10.1177/2042098611425183. Ther Adv Drug Saf. 2012. PMID: 25083222 Free PMC article.
-
Hepatotoxicity of tyrosine kinase inhibitors: clinical and regulatory perspectives.Drug Saf. 2013 Jul;36(7):491-503. doi: 10.1007/s40264-013-0048-4. Drug Saf. 2013. PMID: 23620168 Review.
Publication types
MeSH terms
LinkOut - more resources
Medical